Cargando…
Evaluation of clonal origin of malignant mesothelioma
BACKGROUND: The hypothesis that most cancers are of monoclonal origin is often accepted as a fact in the scientific community. This dogma arose decades ago, primarily from the study of hematopoietic malignancies and sarcomas, which originate as monoclonal tumors. The possible clonal origin of malign...
Autores principales: | Comertpay, Sabahattin, Pastorino, Sandra, Tanji, Mika, Mezzapelle, Rosanna, Strianese, Oriana, Napolitano, Andrea, Baumann, Francine, Weigel, Tracey, Friedberg, Joseph, Sugarbaker, Paul, Krausz, Thomas, Wang, Ena, Powers, Amy, Gaudino, Giovanni, Kanodia, Shreya, Pass, Harvey I, Parsons, Barbara L, Yang, Haining, Carbone, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255423/ https://www.ncbi.nlm.nih.gov/pubmed/25471750 http://dx.doi.org/10.1186/s12967-014-0301-3 |
Ejemplares similares
-
BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs
por: Carbone, Michele, et al.
Publicado: (2012) -
Germline BAP1 mutations predispose to malignant mesothelioma
por: Testa, Joseph R., et al.
Publicado: (2011) -
Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma
por: Carbone, Michele, et al.
Publicado: (2016) -
Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression
por: Yang, H, et al.
Publicado: (2015) -
FTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse model
por: Szymiczek, Agata, et al.
Publicado: (2017)